Grant: Project Grant - PA: Nutrition, Metabolism and Diabetes
University of British Columbia
$100,000.00
SOX4 regulation of human islet cell genesis and growth
FY 2022-23
Summary
Diabetes is a chronic, incurable disease with devastating complications. The hallmark symptom of diabetes is sustained elevation in blood glucose levels, which results from reduced function of the insulin-secreting beta cell within the pancreas. Population studies and DNA sequencing have identified genetic variation that increases the risk of developing diabetes; however, how much of this variation leads to disease is unknown.
Here we propose using cutting-edge technologies to generate human disease models and that carry the genetic differences that predispose to Type 2 diabetes. We will then study how these genetic changes lead to reductions of insulin secretion and likely cause diabetes. We expect these studies to will allow a greater understanding of how genetic variation in some people leads to diabetes and uncover new, human-specific beta cell pathways that could be targeted for development of therapeutics for Canadians with diabetes.
Department
Program
Project Grant - PA: Nutrition, Metabolism and Diabetes
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
484106
Name
Lynn Francis C
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Diabetes, Obesity, Lipid & Lipoprotein Disorders
Projecttitle
SOX4 regulation of human islet cell genesis and growth
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - PA: Nutrition, Metabolism and Diabetes
Keyworddelim
Development; Diabetes; Disease Risk; Stem Cells; Transcription
Abstract
Diabetes is a chronic, incurable disease with devastating complications. The hallmark symptom of diabetes is sustained elevation in blood glucose levels, which results from reduced function of the insulin-secreting beta cell within the pancreas. Population studies and DNA sequencing have identified genetic variation that increases the risk of developing diabetes; however, how much of this variation leads to disease is unknown.
Here we propose using cutting-edge technologies to generate human disease models and that carry the genetic differences that predispose to Type 2 diabetes. We will then study how these genetic changes lead to reductions of insulin secretion and likely cause diabetes. We expect these studies to will allow a greater understanding of how genetic variation in some people leads to diabetes and uncover new, human-specific beta cell pathways that could be targeted for development of therapeutics for Canadians with diabetes.
Competitiondate
202303
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lynn, Francis C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~